AIM ImmunoTech (AIM) EBIT Margin Growth (3y) (2013 - 2026)
AIM ImmunoTech (AIM) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | -377.00 |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | -204.00 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | -537.00 |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | -1,934.00 |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 7,261.00 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 9,003.00 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | -11,254.00 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 30,461.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -2,649.00 |
| 10 | AIM ImmunoTech | 4.42 Mn | -5.55 Mn | 21,000.00 | -50,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -50,916.00 |
| Mar 31, 2026 | -135,288.00 |
| Dec 31, 2025 | -413,571.00 |
| Sep 30, 2025 | 2.16 Mn |
| Jun 30, 2025 | 506,600.00 |
| Mar 31, 2025 | -1.31 Mn |
| Dec 31, 2024 | 187,889.00 |
| Sep 30, 2024 | -91,965.00 |
| Jun 30, 2024 | 877,722.00 |
| Mar 31, 2024 | -96,000.00 |
| Dec 31, 2023 | -928,271.00 |
| Sep 30, 2023 | -841,316.00 |
| Jun 30, 2023 | -465,238.00 |
| Mar 31, 2023 | -137,642.00 |
| Dec 31, 2022 | -374,543.00 |
| Sep 30, 2022 | -2.58 Mn |
| Jun 30, 2022 | -453,276.00 |
| Dec 31, 2021 | -1.38 Mn |
| Sep 30, 2021 | -391,132.00 |
| Jun 30, 2021 | -638,643.00 |